Becker Muscular Dystrophy (BMD): Genetics, Symptoms & Management

Becker Muscular Dystrophy (BMD) is an X-linked recessive disorder caused by DMD gene mutations producing partially functional dystrophin. Allelic with Duchenne (DMD) but milder, later onset.

Genetics & Inheritance

  • X-linked recessive: Males affected; females usually asymptomatic carriers (rarely manifest due to skewed X-inactivation).
  • Mutation: In-frame deletions/duplications in DMD → truncated but partially functional dystrophin.
  • Carrier Testing: Mothers of affected males; genetic counseling for family planning.

Clinical Presentation

  • Onset: 5–15 years (range 2–50+).
  • Proximal weakness: pelvic girdle → difficulty running, climbing stairs, Gowers' sign.
  • Progressive: shoulder girdle, trunk, neck. Calf pseudohypertrophy common.
  • Cardiomyopathy: dilated, often before skeletal symptoms. Leading cause of death.
  • Cognitive: usually normal; some learning/behavioral issues.

Diagnosis

  • CK: markedly elevated (5–100x normal).
  • Genetic testing: MLPA/sequencing of DMD (detects >95%).
  • Muscle biopsy: dystrophin immunohistochemistry (reduced intensity, patchy) if genetic negative.

Management

  • Cardiac Surveillance: Echo/Holter annually from diagnosis; ACEi/ARB/beta-blocker at first sign of dysfunction.
  • Pulmonary: Spirometry, cough assist, NIV as needed.
  • Rehabilitation: PT/OT, stretching, bracing (AFOs), wheelchair when needed.
  • Corticosteroids: Prednisone/deflazacort may slow progression (less evidence than DMD).
  • Emerging Therapies: Exon skipping, gene therapy, utrophin upregulation—clinical trials ongoing.

Prognosis

  • Variable. Mean survival ~40–50 years (improving with cardiac care).
  • Quality of life enhanced by multidisciplinary neuromuscular clinic.

Early cardiac monitoring and genetic counseling are cornerstones of BMD care.

Muscle Strains - Related Articles